Related Experiment Videos

Resistance to etoposide induced by three glucose-regulated stresses in Chinese hamster ovary cells

C S Hughes1, J W Shen, J R Subjeck

  • 1Division of Radiation Biology, Roswell Park Memorial Institute, Buffalo, New York 14263.

Cancer Research
|August 15, 1989
PubMed

Insights

Glucose-regulated proteins induce resistance to Adriamycin and etoposide, suggesting a role for topoisomerase II in this cellular defense mechanism against chemotherapy drugs.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Glucose-regulated proteins (GRPs) are known to confer resistance to Adriamycin.
  • The precise mechanism underlying this cross-resistance phenomenon remains incompletely understood.

Purpose of the Study:

  • To investigate additional agents that induce cross-resistance during a glucose-regulated response.
  • To further elucidate the molecular mechanisms involved in GRP-mediated drug resistance.

Main Methods:

  • Cells were treated with various inducers of glucose-regulated proteins, including anoxia, calcium ionophore A23187, and 2-deoxyglucose.
  • Cellular responses to a panel of chemotherapeutic agents (etoposide, vincristine, actinomycin D, bleomycin, radiation, mitomycin C) were assessed following induction.

Main Results:

  • Substantial resistance to etoposide (a topoisomerase II inhibitor) was observed with anoxia, A23187, and 2-deoxyglucose.
  • Partial resistance was induced against vincristine and actinomycin D.
  • No significant alteration in cellular response was noted for bleomycin or radiation.
  • Mitomycin C showed cellular sensitization with anoxia and 2-deoxyglucose, but not with A23187.

Conclusions:

  • The glucose-regulated response confers cross-resistance to topoisomerase II-targeted agents like etoposide and Adriamycin.
  • Topoisomerase II likely plays a significant role in the resistance mechanism induced by GRPs.

Related Concept Videos